Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia

The study "Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia" surveyed 2200 dermatology practitioners, with 201 (9.1%) responding. The results showed that 81% (n=139) of respondents supported the use of oral minoxidil for androgenetic alopecia (AGA). Support varied significantly (P=.03) by the number of years in practice, with those in practice for over 30 years showing the least support. 92% of respondents (130, n=141) reported feeling comfortable prescribing oral minoxidil, and 83% (116, n=140) found oral minoxidil to be better than its topical formulation. 78% (108, n=139) felt their patients were satisfied with their results, and 89% (124, n=140) felt oral minoxidil was well tolerated by their patients. The study concluded that most prescribers use oral minoxidil as a treatment for AGA and find it to be an effective and tolerable option for patients.